The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions for the ...

Jemperli a Key Oncology Drug for GSK In the first nine months of 2024, Jemperli recorded sales worth £318 million. Sales of the drug are being driven by new patient starts in the United States.

GSK's latecomer to the PD-1/PD-L1 inhibitor category Jemperli has barely started to bring in revenues, and is a world away from the company's hopes of blockbuster revenues by 2031.

The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.

GSK's strengths today are its HIV business ... thanks to recently approved meds Jemperli and Ojjara, indicated for solid tumor cancers and myelofibrosis respectively, a >$3bn per annum immuno ...

GSK’s application is underpinned by the positive ... In January 2025, the European Commission approved the company’s Jemperli in conjunction with chemotherapy for the first-line treatment ...

GSK plc (NYSE:GSK) is a UK-based global biopharmaceutical ... In oncology, while PARP inhibitors remain relatively static, Jemperli shows promising growth, particularly in endometrial cancer ...

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first patient in a Phase 2 trial for its experimental drug ...

GSK (NYSE:GSK) reported mixed results from a Phase 3 study evaluating Zejula, or niraparib, and Jemperli, or dostarlimab, in the treatment of advanced ovarian cancer. The U.K. drugmaker said that ...

The College of Nurses of Ontario (CNO) welcomes the Ontario government's new bill to promote labour mobility in Canada, so we can continue to enable more nurses to provide safe ...

Stroke is the fourth leading cause of death among Hispanic men and the third leading cause for Hispanic women in the United States. Yet, according to CDC reports, only 58% of Hispanic adults can ...